Posts tagged Celldex Therapeutics Inc.


Company Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Presents Data on CDX-1140 at the American Society of Hematology Annual Meeting

Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented data on new product candidate CDX-1140, a fully human antibody …

Read more

Stock Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Completes Acquisition of Kolltan Pharmaceuticals

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today it has completed its previously announced acquisition of Kolltan …

Read more

Roth Capital Reiterates Buy on Celldex Therapeutics, Inc. (CLDX) Following 3Q:16 Results; Shares Rose 14%

In a research report published Tuesday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Celldex …

Read more

Stock Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Announces Acquisition of Kolltan Pharmaceuticals

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that the Company has entered into a definitive agreement to acquire …

Read more

Brean Capital Reiterates Buy on Celldex Therapeutics, Inc. (CLDX) Following Phase II Results in Refractory Melanoma

In a research report published Monday, Brean Capital analyst Jason Wittes reiterated a Buy rating …

Read more

Brean Capital Assumes Buy on Celldex Therapeutics, Inc. (CLDX); Sees 265% Upside for the Stock

Brean Capital analyst Jason Wittes was out with a research report, assuming coverage on shares of Celldex Therapeutics, Inc. …

Read more

Company Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Names Elizabeth Crowley as Chief Product Development Officer

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that the Company has promoted Elizabeth Crowley to the newly created …

Read more

Company Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Reports Second Quarter 2016 Results

Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the second quarter ended June 30, …

Read more

ASCO Updates: Cowen Analysts Weigh In on Exelixis, Inc. (EXEL), Ariad Pharmaceuticals, Inc. (ARIA) and Celldex Therapeutics, Inc. (CLDX)

With more than 30,000 attendees, the American Society of Clinical Oncology (ASCO) annual meeting is …

Read more

Stock Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Reports First Quarter 2016 Results

Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the first quarter ended March …

Read more